Principal Financial Group
AMED

Principal Financial Group’s Amedisys AMED Stock Holding History

Principal Financial Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-74,242
Closed -$7.3M – 2249
2025
Q2 		$7.3M Sell
74,242
-1,146
-2% -$108K ﹤0.01% 1407
2025
Q1 		$6.98M Buy
75,388
+334
+0.4% +$30.8K ﹤0.01% 1433
2024
Q4 		$6.81M Sell
75,054
-472
-0.6% -$43.3K ﹤0.01% 1479
2024
Q3 		$7.29M Sell
75,526
-33,149
-31% -$3.23M ﹤0.01% 1429
2024
Q2 		$9.98M Sell
108,675
-14,170
-12% -$1.31M 0.01% 1263
2024
Q1 		$11.3M Buy
122,845
+3,074
+3% +$288K 0.01% 1251
2023
Q4 		$11.4M Sell
119,771
-563
-0.5% -$52.6K 0.01% 1221
2023
Q3 		$11.2M Sell
120,334
-1,979
-2% -$183K 0.01% 1171
2023
Q2 		$11.2M Sell
122,313
-203,821
-62% -$16.7M 0.01% 1194
2023
Q1 		$24M Buy
326,134
+1,761
+0.5% +$152K 0.02% 735
2022
Q4 		$27.1M Buy
324,373
+434
+0.1% +$39.1K 0.02% 641
2022
Q3 		$31.4M Buy
323,939
+15,746
+5% +$1.88M 0.02% 528
2022
Q2 		$32.4M Sell
308,193
-12,680
-4% -$1.62M 0.02% 551
2022
Q1 		$55.3M Buy
320,873
+88,526
+38% +$13.2M 0.03% 421
2021
Q4 		$37.6M Buy
232,347
+68,203
+42% +$11M 0.02% 569
2021
Q3 		$24.5M Buy
164,144
+2,783
+2% +$579K 0.02% 784
2021
Q2 		$39.5M Sell
161,361
-729
-0.4% -$191K 0.03% 545
2021
Q1 		$42.9M Buy
162,090
+39,734
+32% +$11.2M 0.03% 480
2020
Q4 		$35.9M Sell
122,356
-428
-0.3% -$110K 0.03% 494
2020
Q3 		$29M Sell
122,784
-179
-0.1% -$40.7K 0.02% 524
2020
Q2 		$24.4M Buy
122,963
+22,615
+23% +$4.22M 0.02% 563
2020
Q1 		$18.4M Sell
100,348
-41,029
-29% -$7.3M 0.02% 590
2019
Q4 		$23.6M Sell
141,377
-417
-0.3% -$62K 0.02% 681
2019
Q3 		$18.6M Buy
141,794
+11,403
+9% +$1.48M 0.02% 822
2019
Q2 		$15.8M Sell
130,391
-16,767
-11% -$1.99M 0.01% 947
2019
Q1 		$18.1M Sell
147,158
-109,509
-43% -$13.7M 0.02% 849
2018
Q4 		$30.1M Buy
256,667
+863
+0.3% +$102K 0.03% 512
2018
Q3 		$32M Buy
255,804
+12,652
+5% +$1.4M 0.03% 576
2018
Q2 		$20.8M Buy
243,152
+5,414
+2% +$398K 0.02% 801
2018
Q1 		$14.3M Buy
237,738
+5,632
+2% +$321K 0.01% 1016
2017
Q4 		$12.2M Buy
232,106
+2,847
+1% +$150K 0.01% 1146
2017
Q3 		$12.8M Sell
229,259
-2,429
-1% -$128K 0.01% 1080
2017
Q2 		$14.6M Buy
231,688
+1,511
+0.7% +$88K 0.01% 985
2017
Q1 		$11.8M Buy
230,177
+11,625
+5% +$554K 0.01% 1081
2016
Q4 		$9.32M Buy
218,552
+8,497
+4% +$361K 0.01% 1219
2016
Q3 		$9.96M Buy
210,055
+5,734
+3% +$286K 0.01% 1121
2016
Q2 		$10.3M Buy
204,321
+2,519
+1% +$127K 0.01% 1022
2016
Q1 		$9.76M Buy
201,802
+14,805
+8% +$571K 0.01% 1014
2015
Q4 		$7.35M Buy
186,997
+8,329
+5% +$333K 0.01% 1150
2015
Q3 		$6.78M Sell
178,668
-31,808
-15% -$1.34M 0.01% 1177
2015
Q2 		$8.36M Buy
210,476
+1,830
+0.9% +$57K 0.01% 1123
2015
Q1 		$5.59M Buy
208,646
+6,451
+3% +$182K 0.01% 1326
2014
Q4 		$5.93M Buy
202,195
+2,229
+1% +$55K 0.01% 1293
2014
Q3 		$4.03M Sell
199,966
-10,748
-5% -$207K 0.01% 1443
2014
Q2 		$3.53M Buy
210,714
+13,934
+7% +$197K 0.01% 1550
2014
Q1 		$2.93M Buy
196,780
+7,345
+4% +$113K 0.01% 1584
2013
Q4 		$2.77M Buy
189,435
+13,359
+8% +$215K 0.01% 1604
2013
Q3 		$3.03M Buy
176,076
+9,967
+6% +$148K 0.01% 1523
2013
Q2 		$1.93M Buy
+166,109
New +$1.9M ﹤0.01% 1609

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Principal Financial Group's AMED Position: Q3 2025 in Review

Principal Financial Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 74,242 shares — an estimated $7.3M sold.

Principal Financial Group first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $55.3M in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Principal Financial Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Principal Financial Group sold 74,242 Amedisys shares in Q3 2025, an estimated $7.3M.
  • Principal Financial Group first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Principal Financial Group's Amedisys position peaked at $55.3M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Principal Financial Group's 13F filing for Q3 2025, filed 4 Nov 2025.